ESPE Abstracts

ESPE Abstracts

Scientific Programme, ePosters & Abstracts

Published by BioScientifica
Previous issue | Volume 97 | ESPE2023 | Next issue

61st Annual ESPE (ESPE 2023)

Free Communications

GH and IGFs

Previous section
Fetal, neonatal endocrinology and metabolism (to include hypoglycaemia) & Multisystem endocrine disorders
Table of contents
Next section
Thyroid

hrp0097fc11.1 | GH and IGFs

GH replacement therapy with once-weekly somapacitan in children with GH deficiency is effective and well-tolerated: 2-year results from REAL4

hrp0097fc11.2 | GH and IGFs

Clinical characteristics of heterozygous ACAN gene variants and longer-term response to growth hormone treatment: real-world data

hrp0097fc11.3 | GH and IGFs

Analysis of a large panel of genes in a cohort of patients with severe short stature: detection rate and genotype-phenotype correlations

hrp0097fc11.4 | GH and IGFs

Long-term GH-treatment of children born small for gestational age (SGA) does not result in cerebrovascular abnormalities in adulthood compared to untreated controls

hrp0097fc11.5 | GH and IGFs

Effective GH Replacement with Once-weekly Somapacitan in Japanese Children with GH Deficiency: 2-year Results from REAL4

hrp0097fc11.6 | GH and IGFs

Longitudinal analysis of the risk of brain tumour recurrence or progression in relation to the timing of commencement of growth hormone replacement therapy.

Published by BioScientifica

ESPE Abstracts

© Bioscientifica 2026 | Privacy policy | Cookie settings

Bioscientifica Abstracts is the gateway to a series of products that provide a permanent, citable record of abstracts for biomedical and life science conferences.

Find out more